The synthesis of the triol that has been proposed to be the marine natural product sclerophytin F has been completed along with the syntheses of three diastereomers. Comparison of the NMR data for all four compounds to the data reported for the natural product reveals that sclerophytin F is not the 3S diastereomer of sclerophytin A as proposed by Friedrich and Paquette. Re-analysis of the NMR data for known sclerophytin natural products and synthetic analogues leads to the conclusion that sclerophytins E and F are the same compound. This finding has allowed structural reassignment of several other cladiellin natural products.
Introduction
The cladiellins (also termed eunicellins) are a large family of C-2,C-11 cyclised ether-bridged cembranoids that have been isolated from various marine invertebrates.
[1] The compounds display significant structural diversity with regard to the type and position of substituents adorning the C20 skeleton and exhibit a range of biological activities. Members of the sclerophytin subclass of the cladiellin natural products possess a high degree of oxygenation in the medium-ring and have ester or hydroxyl groups located at the C-3, C-6 and C-7 positions (Figure 1 ). The first members of the sclerophytin sub-class to be isolated were sclerophytins A and B (Figure 1) . [2] These compounds were reported to be doubly ether-bridged compounds with the stereochemically ambiguous structures 1 and 2 ( Figure 1 ). Sclerophytin A was reported to display potent activity against the L1210 leukemia cells at a concentration of 1 ng mL -1 . [2] Contemporaneous synthetic studies by the research groups of Paquette and Overman showed that the structures (1 and 2) assigned to sclerophytins A and B were incorrect.
[4] After painstaking detective work, Paquette, Overman and their coworkers deduced that sclerophytin A is the triol 3 and that sclerophytin B is the C-6 acetate (4), then synthesised both natural products to prove their structures (Figure 1 ).
[4d-g] Several other groups have verified the structures of sclerophytins A and B by total synthesis, [5] and the structures of the closely related natural products sclerophytin F methyl ether (5) (which should be re-named sclerophytin A methyl ether) and patagonicol (6) have been confirmed by X-ray crystallography ( Figure 1 ). [6, 7] In 1989, Alam and co-workers isolated and characterized four additional sclerophytins (C-F) from the soft coral Sclerophytum capitalis; the structure of sclerophytin C (7), which bears an additional hydroxyl group at C-8, was confirmed by X-ray crystallography (Figure 1) . [3] The research groups of Ochi and Shibata, and of Rao and Faulkner isolated several compounds of the same type, including litophynin E, 6-acetoxy litophynin E, 6-ethoxy sclerophytin E and 6-isovaleroyl sclerophytin E, from soft corals and also re-isolated some of the sclerophytins that had been discovered by Alam and co-workers. [8] [9] [10] In 2002, Friedrich and Paquette raised doubts about the stereochemical assignments given to sclerophytins E and F by Alam and co-workers and also the assignments given to litophynin E, 6-acetoxy litophynin E, 6-ethoxy sclerophytin E and 6-isovaleroyl sclerophytin E. [11] Friedrich and Paquette reanalysed the NMR data for all members of the sclerophytin family and concluded that sclerophytin E, sclerophytin F, litophynin E, 6-acetoxy litophynin E, 6-ethoxy sclerophytin E and 6-isovaleroyl sclerophytin E are compounds 8-13 ( Figure 2 ) possessing inverted configuration at C-3 compared to sclerophytins A and B (Figure 1 ). Friedrich and Paquette based their structural reassignments for the whole group mainly on the basis of the large 13 C NMR chemical shift differences (+11.8 and -7.1 ppm) between the peaks arising from C-3 and C-18 in the supposed triol sclerophytin F when compared to the corresponding peaks in 13 C NMR spectrum of sclerophytin A. [11] R 1 = H R 1 = Ac R 1 = Et R 1 = COi-Bu 
Results and Discussion
At the outset, our objective was to confirm or disprove the reassigned structure of sclerophytin F by synthesising the triol 9. [12] Retrosynthetic analysis of this compound was undertaken as shown in Scheme 1. Replacement of the hydroxyl groups at C-6 and C-7 with an alkene and masking of the C-3 hydroxyl group leads to the diene i. Removal of the methylene group (C-20) and replacement of a side-chain methyl substituent with a carbonyl group reveals the diketone ii. Replacement of the C-11 carbonyl group with an enol ether spanning C-10-C-11 leads to the ketone iii and Diels-Alder bond disconnection at C-12-C-13 and C-14-C-1 affords the diene iv. Scheme 1. Retrosynthetic analysis of the proposed structure of sclerophytin F.
In the synthetic route implied by the retrosynthetic analysis (Scheme 1), installation of the C-3 methyl substituent is to be performed at an early stage. This contrasts with the strategy employed during our recent total syntheses of sclerophytins A and B -targets possessing R configuration at C-3 -in which the C-3 methyl group was introduced at a very late stage.
[5c] In the proposed synthesis of sclerophytin F, introduction of C-3 methyl substituent would be performed prior to formation of the bridgedbicyclic ether v by rearrangement of the free or metal-bound oxonium ylide that is a presumed intermediate this key transformation. In adopting this approach, we were aware that the substrate might behave differently in the key reaction, compared to related substrates, resulting in poor yields and low levels of diastereocontrol. The ketone 16 required for the reductive cyclisation reaction could be prepared from a commercially available lactone instead (Scheme 3). Lactone 20, the antipode (S enantiomer) of the requisite starting material, was used to explore the viability of the route because it is more readily available than the R enantiomer. Conversion of the carboxylic acid into the acid chloride and treatment with methylmagnesium bromide delivered the methyl ketone 21. [15] In previous work, we had shown that copper-or rhodiumcatalysed reactions of the α-diazo ketone 23 (lacking a C-3 methyl group) deliver the isomeric bridged-bicyclic ethers Z-and E-24 in excellent yield and that the product ratio is dependent on the metal complex employed as the catalyst and the reaction conditions (Scheme 4).
[5c,13b,16] We had also shown that the reaction of the α-diazo ketone 23 can be tuned to give either Zor E-24 as the major product (>6:1 selectivity) by selecting the appropriate catalyst and solvent. However, it was unclear what influence the methyl substituent at the 3-position of the tetrahydropyran would have on the reaction yield or the product ratio. It was conceivable that the substrate 19 would undergo the key reaction in poor yield and/or deliver the isomeric products with low selectivity. The metal-catalysed reaction of the α-diazo ketone 19 to give the isomeric bridged-bicyclic ethers Z-25 and E-25 was explored.
In preliminary experiments, a copper or rhodium complex was employed as the catalyst and reactions were performed in dichloromethane at reflux (Scheme 5 and Table 1 ). In contrast to what had been observed for reactions of the α-diazo ketone 23, [5c,13b] the Z-isomer (Z-25) was the major or sole product in every case. The highest yield (98%) was obtained when copper(II) hexafluoroacetylacetonate was employed as the catalyst, but the diastereoselectivity (1.8:1, Z:E) was low (entry 2, Table 1 ). The use of rhodium(II) acetate as the catalyst afforded a higher degree of selectivity (7.5:1, Z:E) but the yield was less impressive (entry 3, Table 1 ). The Z-isomer was obtained exclusively when rhodium(II) triphenyl acetate was employed as the catalyst, but in this case the yield was very low (entry 8, Table 1 It was not possible to identify a catalyst that would deliver both a high yield and good stereoselectivity. Fortunately, the less thermodynamically favourable isomer, E-25, could be converted into Z-25 by treatment with ethanethiol under radical conditions (Scheme 5).
[17] This discovery meant that the mixture of isomeric products obtained from the high-yielding reaction catalysed by copper(II) hexafluoroacetylacetonate could be converted into a single compound in high yield. The ketone Z-25 was crystalline (in racemic form) and so the structure of this compound was verified by single crystal X-ray crystallography. [18] On the basis of the results obtained during the initial screen of various copper and rhodium complexes (Table 1) , copper(II) hexafluoroacetylacetonate and rhodium(II) perfluorobutyramide were selected as catalysts in order to explore the influence of solvent and temperature on reaction yield and stereoselectivity (Table 2 and Scheme 5). These results revealed that copper(II) hexafluoroacetylacetonate catalysed reactions are generally lower yielding when performed in solvents (entries 1-5, Table 2 ) other than dichloromethane (entry 2, Table 1 ). However, higher stereoselectivity (>20:1, Z:E) is obtained when the reaction is performed in THF (entry 1, Table 2 ). We also discovered that rhodium(II) perfluorobutyramide catalysed reactions are low yielding when performed in solvents (entries 6-8, Table 2 ) other than dichloromethane (entry 4, Table 1 ), but the reactions are more stereoselective. However, when the reaction is performed in 1,2-dichloroethane at reflux (entry 9, Table 2 ), a higher yield (68%) is obtained and the reaction is relatively stereoselective (6.3:1, Z:E). Stereoselective construction of the bridged-bicyclic ether Z-25 meant that elaboration of this compound to give the tricyclic cladiellin core could be investigated (Scheme 6). The synthetic strategy employed was analogous to the one used by us to synthesise related members of the cladiellin family of natural products.
[5c, 13] Conversion of the ketone Z-25 into the enol triflate followed by Heck coupling with ethyl vinyl ether afforded the diene 26. Intermolecular thermal Diels-Alder cycloaddition of the diene 26 with methyl vinyl ketone afforded tricyclic ketone 27 in excellent yield (69% over three steps) as a mixture of exo and endo isomers (1:1 diastereomeric mixture at C-14). Attempted epimerisation of the diastereomeric mixture of ketones 27 using potassium carbonate, sodium hydroxide, sodium methoxide or potassium t-butoxide in methanol or ethanol, or by employing DBU in an aprotic solvent, failed to alter the ratio of diastereomers significantly. Fortunately, treatment of the mixture of isomers with HCl in methanol resulted in hydrolysis of the enol ether and cleavage of TBS ether with concomitant epimerisation at the C-14 stereocentre to give the crystalline diketone 28 as a single isomer in good yield. The structure of this compound (racemic form) was confirmed by single crystal X-ray crystallography. [18] O Selective functionalisation of the diketone 28 was necessary in order to elaborate this compound to give the proposed structure of sclerophytin F. Surprisingly, methylenation of the the diketone 28 using a conventional Wittig reaction afforded a separable mixture of the diene 29 (69% yield) and the triene 30 (14% yield), without formation of the product arising from monomethylenation of the methyl ketone (Scheme 7). Protection of the tertiary alcohol in the diene 29 as a TES ether followed by addition of methylmagnesium chloride completed the carbon framework and delivered the alcohol 31 in good yield (Scheme 8). Side-chain deoxygenation was then performed using the procedure developed by Barrett and coworkers, [19] which has recently employed by Kim and co-workers and by us to prepare related cladiellin natural products.
[5c, 13b,20] Thus, acetylation of the alcohol followed by treatment of the ester with potassium, 18-crown-6 and t-butylamine in THF at room temperature afforded the silyl ether 32 and the alcohol 33 in a combined yield of 56%. Subjection of the silyl ether 32 to acid-catalysed deprotection gave the crystalline alcohol 33 in high yield and its structure was confirmed by X-ray crystallography (Scheme 8). [18] The trisubstituted alkene of the diene 33 was epoxidised stereoselectively using m-chloroperbenzoic acid (Scheme 9). Attempted opening of the epoxide 34 to give a triol by exposure to scandium(III) triflate, [5a] afforded the C-6 allylic alcohol 35
instead. Treatment of the epoxide 34 with aqueous acid produced the allylic alcohol 35 in higher yield (77%) along with the triol 36 in 15% yield. The structure of the crystalline allylic alcohol 35 was confirmed by X-ray crystallography. [ In order to prepare the compound that had been proposed to be sclerophytin F (i.e. the triol 9) from the allylic alcohol 35, it was necessary to invert the configuration at the C-6 stereocentre (Scheme 10). Inversion of configuration was performed by sequential oxidation of the allylic alcohol 35 with the Dess-Martin periodinane and reduction of the intermediate enone under Luche conditions. This sequence delivered the required allylic alcohol 37 (57% yield) along with the original C-6 diastereomer 35 (38% yield). The synthesis of the triol 9 was completed by Sharpless asymmetric epoxidation to deliver the crystalline C-7 spiro-epoxide 38, the structure of which was confirmed by X-ray crystallography, [18] and subsequent reductive opening at the less hindered position using diisobutylaluminium hydride (DIBAL-H). Scheme 11. Syntheses of the triols 36, 41 and 42 corresponding to the C-6 and C-7 diastereomers of proposed structure of sclerophytin F.
Comparison of the 1 H and 13 C NMR data obtained for the triol 9 to those reported for natural sclerophytin F showed that these compounds are not the same. It was conceivable that we had prepared a diastereomer of sclerophytin F and so the syntheses of the diastereomeric triols possessing varying configurations at C-6 and C-7 were undertaken. All three compounds were prepared from the diol 35, a compound that served as an advanced intermediate for the synthesis of the triol 9.
Vanadium-catalysed epoxidation of the allylic alcohol 35 with t-butyl hydroperoxide afforded a separable mixture of the diastereomeric (C-7) crystalline spiro-epoxides 39 and 40 (1:1.6 ratio) in 73% yield (Scheme 11), the structures of which were confirmed by X-ray crystallography. 18 Opening of the epoxide 39 at the less hindered position using DIBAL-H delivered the target triol 41 in modest yield. Treatment of the diastereomeric epoxide 40 under the same conditions produced the second target triol 36. The triol 36 had been obtained as a minor product upon treatment of the epoxide 34 with aqueous acid (Scheme 9). The final compound required for comparison purposes, triol 42, was obtained by oxidation of the triol 36 using Dess-Martin periodinane and reduction of the resulting keto diol with DIBAL-H (Scheme 11). Although the triol 42 was obtained in low yield over the two steps along with triol 36, a sufficient quantity of this compound was prepared to enable full characterization. The 1 H and 13 C NMR data for the triols 9, 36, 41 and 42 were compared to the data reported for sclerophytin F (Table 3) . [3] Significant differences between the 13 C NMR data for all four triols and those of sclerophytin F were immediately obvious, particularly between the 13 C NMR signals for C-3, C-6 and C-7. The four diastereomeric triols (9, 36, 41 and 42) possessing S configuration at C-3 had been prepared and none of these compounds was sclerophytin F. The fact that these triols did not correspond to natural product meant that further comparison of the NMR data for related compounds was required in order to deduce the structure of sclerophytin F.
In a further attempt to identify sclerophytin F, the 1 H and 13 C NMR data for the four triols possessing R configuration at C-3 were considered. One of the compounds in this group is sclerophytin A and it is clear that this natural product is not the same as sclerophytin F. We prepared the diastereomeric triol 44 (7-epi-sclerophytin A) by diastereoselective dihydroxylation of the diene 43, [21] a compound that had served as a key intermediate during our synthesis of vigulariol (Scheme 12). Sclerophytin A, 7-epi-sclerophytin A (44) plus two other diastereomeric compounds with varying configurations at C-6 and C-7 had been prepared by Paquette and co-workers.
These workers reported that reduction of the hydroxyketone 45 delivers the triols 44 and 46 and that the choice of reducing agent dictates the stereochemical outcome of the reaction (Scheme 13). Comparison of the 1 H and 13 C NMR data for our triol 44 with those reported by Paquette and co-workers revealed that our triol is identical to the compound produced by reduction of the hydroxyketone 45 using DIBAL-H but identifed as the triol 46 by Paquette and co-workers. [4e,f] Given that the compound prepared by us is known to be the syn 1,2-diol resulting from dihydroxylation of a Z-alkene, we are confident that the structures assigned to the triols 44 and 46 by Paquette and coworkers are incorrect and that the compound produced by reduction of the hydroxyketone 45 with DIBAL-H is in fact the triol 44 rather than the triol 46. The 1 H and 13 C NMR data for sclerophytin F were compared to those of sclerophytin A, the triol 44 and the two other diastereomeric triols prepared by Paquette and co-workers that possess R configuration at C-3.
[4e,f] The NMR data for the four triols did not match those reported for sclerophytin F. At this stage, six of the eight diastereomeric triols with varying configurations at C-3, C-6 and C-7 had been prepared by us and the remaining two had been reported by Paquette and coworkers. None of these diastereomeric triols was sclerophytin F and so in order to identify the natural product it was necessary to re-analyse and compare the original NMR data to those reported for closely related cladiellin natural products.
Inspection of the data reported by Alam and co-workers for sclerophytins E and F reveals some anomalies and raises doubts about the assignments for both compounds. [3] The first problem is that the mass spectrum given for sclerophytin F is not consistent with the assigned molecular formula (C20H34O4). The molecular ion is given as 363 whereas the mass of the molecular ion for sclerophytin F should be 338, if the molecular formula is correct. The heaviest ion in the mass spectrum for sclerophytin E appears at 338 which could mean that ionisation has resulted in loss of the acetate group or that this compound is actually a triol with molecular formula C20H34O4. Finally, the chemical shifts for the carbon framework signals in the 13 C NMR spectra for sclerophytins E and F are almost identical and the chemical shifts of the signals corresponding to C-3 differ by only 0.3 ppm, which is inconsistent with sclerophytin E being the C-3 acetate of sclerophytin F. A chemical shift difference of several ppm would be expected on the basis of the observed differences in the 13 C NMR spectra of sclerophytins A (3) and B (4), for example ( Figure 1) . The 1 H NMR spectra for sclerophytins E and F are also very similar and the chemical shifts and coupling constants are identical for many signals. It should be appreciated that comparison of data for sclerophytins E and F is complicated by the fact that the original publication describing their isolation contains significant typographical errors. [3] Inspection of the 13 C NMR data for the closely related natural products 3-6 (Figure 1) , [2, 6, 7] the structures of which have been verified by total synthesis or X-ray crystallography, and comparison with the 13 C NMR data for sclerophytin F reveals some interesting trends (Table 4) . It is clear that the 13 C NMR data for sclerophytin F are very similar (≤0.3 ppm chemical shift difference) to those of sclerophytin A, apart from the chemical shifts of the signals arising from C-2-C-5 and C-18. This observation suggests the compounds are very similar but the C-3 hydroxyl group of sclerophytin F is functionalised in some way. Another significant observation is that the 13 C NMR data for sclerophytins E and F are very similar to those of sclerophytin C (7), especially with regard to the signals arising from C-2-C-5 and C-18. The only major differences are between the signals resulting from the C-6-C-9, as a consequence of the C-8 hydroxyl group in sclerophytin C (Table 4) . Comparison of the 13 C NMR data for sclerophytins E and F with those of the other sclerophytin natural products reassigned by Friedrich and Paquette as having S configuration at C-3, shows that the compounds are very similar (Table 5 ). Significant differences in chemical shift are restricted to signals corresponding to C-5-C-7, suggesting that the C-6 substituent accounts for the structural differences between the compounds. NMR data for sclerophytin A (3) and the seven other diastereomeric triols having R or S configuration at C-3, C-6 and C-7, and comparison of these data to those of the natural products 4-7, 6-ethoxy sclerophytin E, 6-valeroyl sclerophytin E and litophynin E leads us to the conclusion that sclerophytin F is simply re-isolated sclerophytin E, a finding that is consistent with the original mass spectrometry data. [3] Based on all the available data, and in particular comparison of the 13 C NMR data for sclerophytin E with those of sclerophytins A and C, it is clear that sclerophytin E is the C-3 acetate of sclerophytin A. This is the structure that was assigned to sclerophytin E by Alam and coworkers [3] and by Rao, Faulkner and co-workers, [9] prior to the structural reassignment of several sclerophytins by Friedrich and Paquette in 2002. [11] The fact that sclerophytins E and F are the same compound is particularly evident when appreciates that the 13 C NMR data for the triols 9, 36, 41 and 42 show a much lower degree of homology than do the 13 C NMR data for sclerophytins E and F, even though the four triols have simple diastereomeric relationships (Table 3) . The failure of Alam and co-workers to report the signals corresponding the acetate group in the 13 C NMR spectrum of sclerophytin F is puzzling, but could be explained by overlap of the 13 C NMR signal of the acetate methyl group (δ 22.6 ppm)
with that of C-19 (δ 22.7 ppm) and the use a very weak sample leading to a low intensity signal for the carbonyl group. In the 1 H NMR spectrum of sclerophytin F, the signal arising from the acetate methyl group (reported to appear at δ 2.02 ppm in the 1 H NMR spectrum of sclerophytin E) could have been attributed to, or obscured by, the presence of water in the NMR sample. [22] The discovery that sclerophytins E and F are the same compound and that the original structural assignment for sclerophytin E is correct means that we are able to correct the structures of related sclerophytin-type natural products that were reassigned incorrectly by Friedrich and Paquette.
[11] Thus, sclerophytin E/F (47) is the C-3 acetate of sclerophytin A and 6-ethoxy sclerophytin E, 6-isovaleroyl sclerophytin E are compounds 48 and 49 i.e. sclerophytin E has the structure proposed originally by Alam and co-workers and the others have the structures assigned by Rao, Faulkner and co-workers ( Figure 3 ). [9] The very close correlation between the 13 C NMR data for sclerophytin E and litophynin E suggests that the only difference between these compounds is the type of ester group at C-3 and that litophynin E is ester 50, which is the C-7 diastereomer of the compound proposed by Ochi and coworkers following their isolation of the natural product. [8a] It then follows that 6-acetoxy litophynin E is the diester 51 ( Figure 3 ). 
Conclusions
The compound purported to be sclerophytin F and three diastereomeric (at C-6 and C-7) triols have been synthesised. The NMR data for each of these compounds do not match the data reported for sclerophytin F. Analysis of the NMR data for the four known triols that are diastereomers with respect to their configuration at C-3, shows that none of these compounds is sclerophytin F either. Careful re-analysis of the 13 C NMR data for the natural products 3-7 plus the NMR data for sclerophytin E, sclerophytin F, 6-ethoxy sclerophytin E, 6-isovaleroyl sclerophytin E and litophynin E leads us to the conclusion that sclerophytins E and F are the same compound. The structures proposed by Friedrich and Paquette for sclerophytin E, sclerophytin F and related natural products are incorrect and these compounds are those shown in Figure 3 . All of the sclerophytins possess the sclerophytin A skeleton but are esterified at the C-3 hydroxyl group and/or functionalized at the C-6 hydroxyl site i.e. none of the natural sclerophytins possesses inverted configuration at C-3. The structures of compounds 47-51 are those proposed previously by Rao, Faulkner and co-workers. [9] 
